ArticlemAbs
CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibody.
Cristina Melero et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
trialcites it